BioSpace News Archive

Study of Kintor’s c-Myc Degrader Published in Subsidiary Journal of Nature

Kintor Pharmaceutical Limited announces that Kintor and its cooperative partner had published an article named MYC Induces CDK4/6 Inhibitors Resistance by Promoting pRB1 Degradation in a subsidiary journal of Nature—Nature Communications.

March 13, 2024
·
2 min read
Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds

Orexo AB, has successfully issued new senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years.

March 13, 2024
·
4 min read
Business

Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates

Spruce Biosciences, Inc. (Nasdaq: SPRB) today reported financial results for the year ended December 31, 2023 and provided corporate updates.

March 13, 2024
·
10 min read
Pharm Country

Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing

Lexeo Therapeutics, Inc., a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease, announced the closing of its previously announced private placement.

March 13, 2024
·
5 min read
Business

KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2023.

March 13, 2024
·
20 min read